N/A
Completed N=39
Does the Use of Continuous Glucose Monitoring (CGM) in the Immediate Postpartum Period in Women With Pregestational Diabetes Admitted to the Hospital Decrease Hypoglycemic Episodes
Pregestational Diabetes
Source: ClinicalTrials.gov NCT06141941 ↗
Enrolled (actual)
39
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcomePrimary: Number of Participants With Hypoglycemia During Postpartum Hospital Stay — 5; 2; 4; 5 participants
Summary
This study will examine whether continuous glucose monitoring in patients hospitalized in the immediate postpartum period is more effective than traditional point of care glucose testing in identifying patients with hypoglycemia.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Hypoglycemia During Postpartum Hospital Stay |
5; 2; 4; 5 | — |
Eligibility Criteria
Inclusion:
1- Individuals in the third trimester of pregnancy admitted to the hospital with diabetes type 1 or diabetes type 2, own a smart device (which will serve as a receiver for the CGM device)
Exclusion:
- Patients less than 18 years of age
- non-English speaking patients
- gestational diabetes
- extensive skin changes/diseases that inhibit wearing a sensor on normal skin, known allergy to adhesives
Data sourced from ClinicalTrials.gov (NCT06141941). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.